Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anthem, Inc. stock logo
ANTX
Anthem
$3.82
-8.4%
$4.06
$1.00
$6.91
$150.19M-0.98224,388 shs178,156 shs
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
$17.74
+0.9%
$20.83
$89.95
$99.05
$514.19M0.9553,591 shs3.51 million shs
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
$10.44
-6.8%
$9.45
$2.35
$11.55
$310.61M-0.39486,688 shs1.30 million shs
LWAC
LightWave Acquisition
$10.21
0.0%
$10.19
$9.81
$10.21
$307.07MN/A4,080 shs188 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anthem, Inc. stock logo
ANTX
Anthem
-2.31%-6.19%-10.79%+47.07%+283.85%
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
-0.90%-18.19%-28.26%+26.73%+142.62%
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
-6.79%-12.71%+7.74%+41.27%+709.30%
LWAC
LightWave Acquisition
+0.30%+0.39%+0.59%+1.19%-32.68%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anthem, Inc. stock logo
ANTX
Anthem
$3.82
-8.4%
$4.06
$1.00
$6.91
$150.19M-0.98224,388 shs178,156 shs
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
$17.74
+0.9%
$20.83
$89.95
$99.05
$514.19M0.9553,591 shs3.51 million shs
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
$10.44
-6.8%
$9.45
$2.35
$11.55
$310.61M-0.39486,688 shs1.30 million shs
LWAC
LightWave Acquisition
$10.21
0.0%
$10.19
$9.81
$10.21
$307.07MN/A4,080 shs188 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anthem, Inc. stock logo
ANTX
Anthem
-2.31%-6.19%-10.79%+47.07%+283.85%
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
-0.90%-18.19%-28.26%+26.73%+142.62%
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
-6.79%-12.71%+7.74%+41.27%+709.30%
LWAC
LightWave Acquisition
+0.30%+0.39%+0.59%+1.19%-32.68%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anthem, Inc. stock logo
ANTX
Anthem
2.00
Hold$9.00135.60% Upside
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
0.00
N/AN/AN/A
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
0.00
N/AN/AN/A
LWAC
LightWave Acquisition
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest ANTX, AVTE, ELYM, and LWAC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2026
Anthem, Inc. stock logo
ANTX
Anthem
UpgradeMarket PerformOutperform$9.00
5/1/2026
LWAC
LightWave Acquisition
UpgradeSell (E+)Sell (D-)
4/7/2026
Anthem, Inc. stock logo
ANTX
Anthem
Initiated CoverageSell (D-)
(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anthem, Inc. stock logo
ANTX
Anthem
N/AN/AN/AN/A$1.94 per shareN/A
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
N/AN/AN/AN/A$3.96 per shareN/A
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
N/AN/AN/AN/A$3.90 per shareN/A
LWAC
LightWave Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anthem, Inc. stock logo
ANTX
Anthem
-$35.17M-$1.10N/AN/AN/AN/A-52.35%-47.25%N/A
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
-$75.52M-$1.70N/AN/AN/AN/A-90.19%-77.47%N/A
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
-$35.12M-$0.53N/AN/AN/AN/A-47.03%-45.97%N/A
LWAC
LightWave Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest ANTX, AVTE, ELYM, and LWAC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
LWAC
LightWave Acquisition
N/A$0.06N/A$0.06N/AN/A
5/11/2026Q1 2026
Anthem, Inc. stock logo
ANTX
Anthem
-$0.23-$0.29-$0.06-$0.29N/AN/A
3/17/2026Q4 2025
Anthem, Inc. stock logo
ANTX
Anthem
N/A-$0.29N/A-$0.29N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Anthem, Inc. stock logo
ANTX
Anthem
N/AN/AN/AN/AN/A
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
N/AN/AN/AN/AN/A
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
N/AN/AN/AN/AN/A
LWAC
LightWave Acquisition
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anthem, Inc. stock logo
ANTX
Anthem
N/A
15.73
15.73
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
N/A
8.78
8.78
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
N/A
60.41
60.41
LWAC
LightWave Acquisition
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Anthem, Inc. stock logo
ANTX
Anthem
90.47%
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
N/A
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
69.76%
LWAC
LightWave Acquisition
N/A

Insider Ownership

CompanyInsider Ownership
Anthem, Inc. stock logo
ANTX
Anthem
24.46%
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
24.90%
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
4.70%
LWAC
LightWave Acquisition
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Anthem, Inc. stock logo
ANTX
Anthem
N/A36.02 million27.21 millionNot Optionable
Aerovate Therapeutics, Inc. stock logo
AVTE
Aerovate Therapeutics
2028.99 million21.69 millionOptionable
Eliem Therapeutics, Inc. stock logo
ELYM
Eliem Therapeutics
929.75 million28.35 millionNot Optionable
LWAC
LightWave Acquisition
N/A30.08 millionN/ANot Optionable

Recent News About These Companies

LightWave Acquisition Corp. - Ordinary Shares - Class A
LightWave Acquisition Corp. Cl A
Empty stomach walk vs post meal walk; which is better for weight loss?
4 Best Walk-In Tub Shower Combinations (2024)
Locust, NC Weather Conditions
How much should one ideally walk in a day to stay fit and healthy
The Best Gear for Going on a Walk
Should we install a walk-in tub in our bathroom?
How Much Do Walk-In Tubs Cost?
Best Walk-In Tubs of 2023
Best Walk-In Tubs With Showers 2023
Boca Walk-in Tubs
61st Locust Street Art Annual Art Show

Media Sentiment Over Time

Anthem stock logo

Anthem NASDAQ:ANTX

$3.82 -0.35 (-8.39%)
Closing price 04:00 PM Eastern
Extended Trading
$3.81 -0.01 (-0.34%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Aerovate Therapeutics stock logo

Aerovate Therapeutics NASDAQ:AVTE

$17.74 +0.15 (+0.85%)
As of 06/4/2026

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Eliem Therapeutics stock logo

Eliem Therapeutics NASDAQ:ELYM

$10.44 -0.76 (-6.79%)
As of 06/3/2026

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.

LightWave Acquisition NASDAQ:LWAC

$10.21 0.00 (-0.01%)
Closing price 01:09 PM Eastern
Extended Trading
$10.26 +0.05 (+0.45%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Locust Walk Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.